Last Updated: July 16, 2018
Inception Date: 2000-04-05 00:00:00.0
Date Funded: 2009-08-28*
|Folio||S&P 500 Total Return|
(% of Folio)
|1||ALKS||alkermes pls shr||3.34%|
|2||ALXN||alexion pharmaceuticals inc||3.33%|
|4||ARGX||argenx se sponsored adr||3.34%|
|5||ARRY||array biopharma inc||3.33%|
|6||ASND||ascendis pharma a s sponsored adr||3.33%|
|7||BGNE||beigene ltd sponsored adr||3.33%|
|9||BMRN||biomarin pharmaceutical inc||3.33%|
|10||BPMC||blueprint medicines corp com||3.33%|
|11||CBPO||china biologic prods inc com||3.33%|
|13||EBS||emergent biosolutions inc com||3.33%|
|14||EXAS||exact sciences corp||3.33%|
|15||FOLD||amicus therapeutics inc com||3.34%|
|16||GILD||gilead sciences inc||3.34%|
|17||GLPG||galapagos nv spon adr||3.33%|
|18||HALO||halozyme therapeutics inc||3.34%|
|19||IART||integra lifesciences hldgs cp new||3.34%|
|22||INCY||incyte genomics, inc||3.33%|
|23||LGND||ligand pharmaceuticals inc cl b||3.33%|
|24||QGEN||qiagen n v ord||3.33%|
|25||RARE||ultragenyx pharmaceutical inc com||3.33%|
|27||SGEN||seattle genetics inc||3.33%|
|28||SRPT||sarepta therapeutics inc new||3.33%|
|29||TECH||bio techne corp new||3.34%|
|30||VRTX||vertex pharmaceuticals inc||3.33%|
Steps to Create This Folio
- We selected securities with primary business operations in the Biotechnology industry, as defined by Zacks Investment Research.
- We ranked the securities according to market capitalization and selected 30 securities with the highest market capitalizations.
- We equally weighted all securities in the folio.
Number of Securities
There are generally 30 securities in the folio.
If the characteristics of the folio have changed substantially, the securities included may change. Also, corporate actions, such as a merger, or other events may cause changes to the securities held at any time. Your returns may deviate significantly from the values displayed here, due to many factors, including how long after a folio has been updated that you place orders to update your holdings.